Akso Health Group (NASDAQ:AHG) Rating Increased to Sell at Wall Street Zen

Wall Street Zen upgraded shares of Akso Health Group (NASDAQ:AHG) to a sell rating in a report issued on Saturday.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Akso Health Group in a research note on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Akso Health Group Stock Performance

Shares of AHG opened at $2.14 on Friday. The company’s fifty day moving average is $2.04 and its 200-day moving average is $1.69. Akso Health Group has a 12 month low of $1.07 and a 12 month high of $2.50.

Institutional Trading of Akso Health Group

A hedge fund recently raised its stake in Akso Health Group stock. SmartHarvest Portfolios LLC lifted its holdings in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG) by 111.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 35,429 shares of the company’s stock after acquiring an additional 18,681 shares during the period. SmartHarvest Portfolios LLC’s holdings in Akso Health Group were worth $81,000 as of its most recent filing with the SEC. 1.21% of the stock is owned by institutional investors and hedge funds.

About Akso Health Group

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.